相关实验视频
Updated: Jun 8, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
利用持续葡萄糖监测数据作为葡萄糖处方行为的额外来源
Jayachidambaram Ambalavanan1, Jill Rusticelli1, Diana Isaacs1
1Endocrinology, Diabetes & Metabolism, Medical Sub-specialty Institute, Cleveland Clinic, Cleveland, Ohio.
概括
连续血糖监测 (CGM) 的糖尿病低血糖患者的葡萄糖的处方较低. 提供者教育显著增加了葡萄糖的处方率,提高了患者的安全.
科学领域:
- 内分泌学 在内分泌学.
- 糖尿病管理 糖尿病管理
- 药理学 药理学是指药理学的学科.
背景情况:
- 低血糖症对糖尿病患者构成重大风险.
- 持续葡萄糖监测 (CGM) 提供了关于葡萄糖水平的宝贵数据,包括在低血糖症中花费的时间.
- 葡萄糖是治疗严重低血糖症的关键药物.
研究的目的:
- 根据CGM报告,评估在患有低血糖症的患者中葡萄糖的处方率.
- 评估教育干预对医疗保健提供者关于葡萄糖开处方的影响.
- 为了确定在提供者教育后新的葡萄糖处方的发生率.
主要方法:
- 针对服用特定降血糖药物的糖尿病成年患者的回顾性图表审查.
- 质量改善 (QI) 倡议涉及向提供者提供关于低血糖管理和葡萄糖的教育宣传.
- 分析QI干预之前和之后的葡萄糖处方率,以CGM时间定义的低血糖低于≥4%的范围.
主要成果:
- 在CGM记录低血糖症的患者中 (时间低于范围≥4%),只有37%的患者有先前存在的葡萄糖处方,14%的患者获得了临时处方.
- 随着低血糖症的严重程度,葡萄糖的处方率增加,从轻度病例的38%增加到严重病例的63%.
- 在教育宣传之后,39%的目标提供者处方了葡萄糖,首选的是急救套装,自动注射器和吸入形式.
结论:
- 在糖尿病患者中,葡萄糖的处方率仍然低于最佳水平,在CGM上有记录的低血糖症.
- 通过质量改进计划,提供者参与可以有效地增加葡萄糖的处方.
- 有针对性的教育是改善获得紧急低血糖治疗的可行策略.
相关概念视频
Hypoglycemia and Glucagon
152
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
152
Glucagon-like Receptor Agonists
300
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
300
Hormones Regulating Blood Glucose
3.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.1K
Glucose Homeostasis: Regulation of Blood Glucose
1.4K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
1.4K
Oral Hypoglycemic Agents: Glinides
141
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
141
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.1K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.1K

